HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Broche-Pierre, S. Articles by Sonigo, P. Search for Related Content PubMed PubMed Citation Articles by Broche-Pierre, S. Articles by Sonigo, P. Agricola Articles by Broche-Pierre, S. Articles by Sonigo, P.

Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties

Jennifer Richardson^1,

¹ Génétique des Virus, Institut Cochin (INSERM U567, CNRS UMR8104), 22 rue Méchain, 75014 Paris, France
² UMR INRA-ENVA-AFSSA 1161 de Virologie, Ecole Nationale Vétérinaire d'Alfort (ENVA), 7 rue du Général de Gaulle, 94704 Maisons-Alfort, France

Correspondence
Pierre Sonigo
sonigo{at}cochin.inserm.fr

Live-attenuated viruses have typically been generated from pathogenic viruses by genetic modifications that modified their replicative capacity. The present study investigated whether modification of the antigenic properties of live-attenuated viruses might improve upon the protection that such vaccines afford against lentivirus infection. In a previous study, random amino acid substitutions were introduced into the transmembrane envelope glycoprotein of the feline immunodeficiency virus (FIV), within a highly conserved domain (principal immunodominant domain) bearing immunodominant B-cell epitopes. Amongst a wide set of mutants, mutations that modified antibody specificity without abolishing infectivity ex vivo were selected. In the present study, two such mutants, TN14 and TN92, were evaluated for their replicative capacities and pathogenic properties in vivo in comparison with the parental virus, FIV 34TF10. No significant differences in viral load were observed between mutant and parental viruses. After 1 year of infection, all animals were subjected to a heterologous intraclade superinfection with a primary strain of FIV. Whilst both parental and modified viruses protected cats from high viral loads after superinfection, the TN92 virus afforded a higher degree of protection (P=0·0079). Such improvement in protection might correlate with a decrease in the immunogenicity of a B-cell epitope potentially involved in antibody enhancement of infection.

Present address: UMR INRA-ENVA-AFSSA 1161 de Virologie, ENVA, 7 rue du Général de Gaulle, 94704 Maisons-Alfort, France.

This article has been cited by other articles:

				S. Giannecchini, M. Pistello, P. Isola, D. Matteucci, P. Mazzetti, G. Freer, and M. Bendinelli Role of Env in Resistance of Feline Immunodeficiency Virus (FIV)-Infected Cats to Superinfection by a Second FIV Strain as Determined by Using a Chimeric Virus J. Virol., October 1, 2007; 81(19): 10474 - 10485. [Abstract] [Full Text] [PDF]

				M. Pistello, F. Bonci, J. N. Flynn, P. Mazzetti, P. Isola, E. Zabogli, V. Camerini, D. Matteucci, G. Freer, P. Pelosi, et al. AIDS Vaccination Studies with an Ex Vivo Feline Immunodeficiency Virus Model: Analysis of the Accessory ORF-A Protein and DNA as Protective Immunogens. J. Virol., September 1, 2006; 80(18): 8856 - 8868. [Abstract] [Full Text] [PDF]